Melphalan
CAS No. 148-82-3
Melphalan( L-PAM )
Catalog No. M12056 CAS No. 148-82-3
A chemotherapy agent that acts through alkylation of the DNA nucleotide guanine, and causes linkages between strands of DNA; inhibits DNA synthesis and RNA synthesis in both dividing and non-dividing tumor cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMelphalan
-
NoteResearch use only, not for human use.
-
Brief DescriptionA chemotherapy agent that acts through alkylation of the DNA nucleotide guanine, and causes linkages between strands of DNA; inhibits DNA synthesis and RNA synthesis in both dividing and non-dividing tumor cells.
-
DescriptionA chemotherapy agent that acts through alkylation of the DNA nucleotide guanine, and causes linkages between strands of DNA; inhibits DNA synthesis and RNA synthesis in both dividing and non-dividing tumor cells.Chemotherapeutic Agents Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsL-PAM
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNA Alkylator
-
Research AreaCancer
-
IndicationChemotherapeutic
Chemical Information
-
CAS Number148-82-3
-
Formula Weight305.2002
-
Molecular FormulaC13H18Cl2N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: < 9.2 mg/mL
-
SMILESN[C@@H](CC1=CC=C(N(CCCl)CCCl)C=C1)C(O)=O
-
Chemical NameL-Phenylalanine, 4-[bis(2-chloroethyl)amino]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dudek-Peri? AM, et al. Cancer Res. 2015 Apr 15;75(8):1603-14.
2. Keane MM, et al. Cancer Res. 1999 Feb 1;59(3):734-41.
molnova catalog
related products
-
Altretamine
Altretamine is an alkylating agent proposed as an antineoplastic.
-
Methylnitronitrosogu...
Methylnitronitrosoguanidine (MNNG) is an alkylating agent with toxic and mutagenic effects.
-
Alchemix
A dual action as an alkylating agent and topoisomerase inhibitor with potent activity against anthracycline- and cisplatin-resistant tumor cancer.
Cart
sales@molnova.com